The Wnt-dependent signaling pathways as target in oncology drug discovery Nico JanssensMichel JanicotTim Perera Preclinical Studies Open access 28 January 2006 Pages: 263 - 280
Population pharmacokinetics and bioavailability of motexafin gadolinium (Xcytrin®) in CD1 mice following intravenous and intraperitoneal injection Boswell GWDR MilesM Mesfin Preclinical Studies 09 March 2006 Pages: 281 - 289
Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patients Jing LiJulie BrahmerSharyn D. Baker Preclinical Studies 17 February 2006 Pages: 291 - 297
A phase I Study with oral SU5416 in patients with advanced solid tumors: A drug inducing its clearance Marc SalzbergMiklos PlessRichard Herrmann Phase I Studies 05 October 2005 Pages: 299 - 304
A phase I study of flavopiridol and docetaxel Basil F. El-RayesShirish GadgeelPhilip A. Philip Phase I Studies 28 January 2006 Pages: 305 - 310
A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors Werner HilgersSandrine FaivreEsteban Cvitkovic Phase I Studies 28 January 2006 Pages: 311 - 319
Phase I trial of thalidomide and Interleukin-2 in patients with metastatic renal cell carcinoma Thomas OlenckiSareena MalhiRonald M. Bukowski Phase I Studies 28 January 2006 Pages: 321 - 326
A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors Thierry DelaunoitPatrick A. BurchCharles Erlichman Phase I Studies 17 February 2006 Pages: 327 - 333
Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study Robert P. WhiteheadSheryl McCoyJames L. Abbruzzese Phase II Studies 28 January 2006 Pages: 335 - 341
A phase II study of chloroquinoxaline sulfonamide (CQS) in patients with metastatic colorectal carcinoma (MCRC) Tanios S. Bekaii-SaabAmir MortazaviEric H. Kraut Phase II Studies 28 January 2006 Pages: 343 - 346
SarCNU in recurrent or metastatic colorectal cancer: A phase II study of the National Cancer Institute of Canada Clinical Trials Group R. P. WongT. BaetzE. Eisenhauer Phase II Studies 08 March 2006 Pages: 347 - 351
A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma Jaffer A. AjaniYixing JiangArchie Bleyer Phase II Studies 05 April 2006 Pages: 353 - 357
Phase II study of rubitecan, an oral camptothecin in patients with advanced colorectal cancer who have failed previous 5-fluorouracil based chemotherapy Hitendra PatelRonald StollerRamesh K. Ramanathan Phase II Studies 08 March 2006 Pages: 359 - 363